Document Type : Original Article

Authors

1 Department of Public Health, Health School, Qazvin University of Medical Science, Qazvin, Iran

2 Children Growth Research Center, Research Institute for Prevention of Non Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran

10.30476/jhsss.2024.101564.1883

Abstract

Background: This study aimed to determine the effect of motivational interviewing (MI) on self-control, self-efficacy, and
relapse rate in clients undergoing substance abuse treatment in Foman city, Iran.
Methods: Using a multi-stage random sampling, 72 patients undergoing substance abuse treatment were equally divided into an experimental and control group and participated in this experimental study. Patients participated in eight 45-60- minute motivational interviewing sessions based on Miller’s recommendations. Data were collected before and 3 months after the MI using demographic questions, temptation questionnaire, Tangney’s self-control scale, general self-efficacy scale, and relapse prediction questionnaire (short form).
Results: After controlling the effect of the pretest, the mean of temptation significantly decreased in the experimental group after the MI, and the mean of self-efficacy and self-control increased significantly in the experimental group after the MI (P<0.001). In addition, the mean intensity of desire and the probability of consumption improved significantly in the experimental group after MI, after controlling for the pre-test effect (P<0.001).
Conclusion: MI is a promising approach to reduce the relapse rate in addicted patients receiving treatment. Therefore, it is suggested that the effectiveness of common drug therapy for successful substance abuse treatment can be increased by including MI in the treatment protocol.

Highlights

Taleb Andarz (Google Scholar)

Isa Mohammadi Zeidi (Google Scholar)

Keywords

  1. Takahashi TT, Ornello R, Quatrosi G, Torrente A, Albanese M, Vigneri S, et al. European Headache Federation School of Advanced Studies (EHF-SAS). Medication overuse and drug addiction: a narrative review from addiction perspective. J Headache Pain. 2021; 22(1):32. doi: 10.1186/ s10194-021-01224-8. PMCID: PMC8080402.
  2. Nawi AM, Ismail R, Ibrahim F, Hassan MR, Manaf MRA, Amit N, et al. Risk and protective factors of drug abuse among adolescents: a systematic review. BMC Public Health. 2021; 21(1):2088. doi: 10.1186/s12889-021-11906-2. PMC8590764.
  3. Ghoreishi SMS, Shahbazi F, Mirtorabi SD, Ghadirzadeh MR, Hashemi Nazari SS. Epidemiological Study of Mortality Rate from Alcohol and Illicit Drug Abuse in Iran. J Res Health Sci. 2017; 17(4):e00395. PMID: 29233952.
  4. Saberi Zafarghandi MB, Jadidi M, Khalili N. Iran’s Activities on Prevention, Treatment and Harm Reduction of Drug Abuse. Int J High Risk Behav Addict. 2015; 4(4):e22863. doi: 10.5812/ ijhrba.22863. PMCID: PMC4744908.
  5. Ndasauka Y, Wei Z, Zhang X. Received View of Addiction, Relapse and Treatment. Adv Exp Med Biol. 2017; 1010:3-19. doi: 10.1007/978-981- 10-5562-1_1. PMID: 29098665.
  6. Douglas C. Addiction medicine ethics: relapse, no lapse and the struggle to treat addicts like everyone else. Intern Med J. 2017; 47(10):1121- 1123. doi: 10.1111/imj.13559. PMID: 28994253.
  7. Vo HT, Robbins E, Westwood M, Lezama D, Fishman M. Relapse prevention medications in community treatment for young adults with opioid addiction. Subst Abus. 2016; 37(3):392-397. doi: 10.1080/08897077.2016.1143435. PMID: 26820059.
  8. Scherz C, Mpanga G, Namirembe S. Not You: Addiction, Relapse, and Release in Uganda. Cult Med Psychiatry. 2022; 46(1):101-114. doi: 10.1007/ s11013-021-09722-9. PMID: 33999310.
  9. Karimyar Jahromi M, Eftekharzadeh MH, Hamidipour Z. Assessment meter of various effective factors associated with substance abuse relapse in addict’s perspective. International journal of behavioral sciences. 2015; 13 (1): 124 -133.
  10. Charlotte W, Loshak H, Dulong C. Withdrawal Management and Treatment of Crystal Methamphetamine Addiction in Pregnancy: A Review of Clinical Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun 17. PMID: 31525002.
  11. Wang M, Pinilla G, Leung C, Peddada A, Yu E, Akmal S, et al. Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit. Am J Addict. 2021; 30(5):461-467. doi: 10.1111/ ajad.13192. PMID: 34075661.
  12. Betancourt CA, Kitsantas P, Goldberg DG, Hawks BA. Substance Use Relapse among Veterans at Termination of Treatment for Substance Use Disorders. Mil Med. 2022; 187(11-12):e1422-e1431. doi: 10.1093/milmed/usab280. PMID: 34272857.
  13. Jiang S, Wu L, Gao X. Beyond face-to-face individual counseling: A systematic review on alternative modes of motivational interviewing in substance abuse treatment and prevention. Addict Behav. 2017; 73:216-235. doi: 10.1016/j. addbeh.2017.05.023. PMID: 28554033.
  14. Oveisi S, Stein LAR, Babaeepour E, Araban M. The impact of motivational interviewing on relapse to substance use among women in Iran: a randomized clinical trial. BMC Psychiatry. 2020; 20(1):157. doi: 10.1186/s12888-020-02561- 9. PMC7147038.
  15. Navidian A, Kermansaravi F, Tabas EE, Saeedinezhad F. Efficacy of Group Motivational Interviewing in the Degree of Drug Craving in the Addicts Under the Methadone Maintenance Treatment (MMT) in South East of Iran. Arch Psychiatr Nurs. 2016; 30(2):144-9. doi: 10.1016/j. apnu.2015.08.002. PMID: 26992862.
  16. Almansour M, AlQurmalah SI, Abdul Razack HI. Motivational interviewing-an evidence-based, collaborative, goal-oriented communication approach in lifestyle medicine: A comprehensive review of the literature. J Taibah Univ Med Sci. 2023; 18(5):1170-1178. doi: 10.1016/j. jtumed.2023.03.011. PMCID: PMC10189272.
  17. Self KJ, Borsari B, Ladd BO, Nicolas G, Gibson CJ, Jackson K, Manuel JK. Cultural adaptations of motivational interviewing: A systematic review. Psychol Serv. 2023; 20(Suppl 1):7-18. doi: 10.1037/ ser0000619. PMCID: PMC10161132.
  18. Hayaki J, Conti MT, Bailey GL, Herman DS, Anderson BJ, Stein MD. Negative affect-associated drug refusal self-efficacy, illicit opioid use, and medication use following short-term inpatient opioid withdrawal management. J Subst Abuse Treat. 2021;126:108309. doi: 10.1016/j. jsat.2021.108309. PMCID: PMC8197771.
  19. Abusubhiah M, Walshe N, Creedon R, Noonan B, Hegarty J. Self-efficacy in the context of nursing education and transition to practice as a registered practitioner: A systematic review. Nurs Open. 2023; 10(10):6650-6667. doi: 10.1002/nop2.1931. PMCID: PMC10495721.
  20. Coccini T, Ottonello M, Spigno P, Malovini A, Fiabane E, Roda E, Signorini C, Pistarini C. Biomarkers for alcohol abuse/withdrawal and their association with clinical scales and temptation to drink. A prospective pilot study during 4-week residential rehabilitation. Alcohol. 2021; 94:43- 56. doi: 10.1016/j.alcohol.2021.04.004. PMID: 33887366.
  21. Saunders BT, Robinson TE. Individual variation in resisting temptation: implications for addiction. Neurosci Biobehav Rev. 2013; 37(9 Pt A):1955- 75. doi: 10.1016/j.neubiorev.2013.02.008. PMCID: PMC3732519.
  22. Quancai L, Meng C, Kunjie C. Social control and self-control: factors linking exposure to domestic violence and adolescents’ Internet gaming addiction. Front Psychiatry. 2023; 14:1245563. doi: 10.3389/fpsyt.2023.1245563. PMCID: PMC10480565.
  23. Graczyk MM, Sahakian BJ, Robbins TW, Ersche KD. Genotype-by-diagnosis interaction influences self-control in human cocaine addiction. Transl Psychiatry. 2023; 13(1):51. doi: 10.1038/s41398- 023-02347-z. PMCID: PMC9922269.
  24. Mooijman M, Meindl P, Oyserman D, Monterosso J, Dehghani M, Doris JM, et al. Resisting temptation for the good of the group: Binding moral values and the moralization of self-control. J Pers Soc Psychol. 2018; 115(3):585-599. doi: 10.1037/pspp0000149. PMID: 28604018.
  25. Steimke R, Stelzel C, Gaschler R, Rothkirch M, Ludwig VU, Paschke LM, et al. Decomposing Self-Control: Individual Differences in Goal Pursuit Despite Interfering Aversion, Temptation, and Distraction. Front Psychol. 2016; 7:382. doi: 10.3389/fpsyg.2016.00382. PMCID: PMC4834631.
  26. Sripada C. Impaired control in addiction involves cognitive distortions and unreliable self-control, not compulsive desires and overwhelmed self-control. Behav Brain Res. 2022; 418:113639. doi: 10.1016/j.bbr.2021.113639. PMID: 34710509.
  27. Hammarberg SI, Wallhed Finn S, Rosendahl I, Andréasson S, Jayaram-Lindström N, Hammarberg A. Behavioural self-control training versus motivational enhancement therapy for individuals with alcohol use disorder with a goal of controlled drinking: A randomized controlled trial. Addiction. 2024; 119(1):86-101. doi: 10.1111/ add.16325. PMID: 37658776.
  28. Agbaria Q. Cognitive behavioral intervention in dealing with Internet addiction among Arab teenagers in Israel. Int J Ment Health Addict. 2022:1-15. doi: 10.1007/s11469-021-00733-6. PMCID: PMC8769783.
  29. Asli Khalan Y, Karimi M, Asadollahi A, Kaveh MH. Psychometric Properties of the Persian Version of a Drug Use Temptation Scale. Journal of Health Sciences & Surveillance System. 2020; 8(4): 173-178.
  30. Ziaee SS, Fadardi JS, Cox WM, Yazdi SA. Effects of attention control training on drug abusers’ attentional bias and treatment outcome. J Consult Clin Psychol. 2016; 84(10):861-73. doi: 10.1037/ a0040290. PMID: 27281374.
  31. Hemati M, Mahdad A, Aghaei Jashooghani A. Designing an Emotional Regulation Training Package based on the needs of people who leave the drug and examining its effectiveness on cognitive disturbances and drug use temptation. Journal of Applied Psychological Research. 2017; 8(3): 186-199.
  32. Tangney JP, Baumeister RF, Boone AL. High self-control predicts good adjustment, less pathology, better grades, and interpersonal success. J Pers. 2004; 72(2):271-324. doi: 10.1111/j.0022- 3506.2004.00263.x. PMID: 15016066.
  33. Asgarian FS, Namdari M, Soori H. Reliability and validity of Persian version of Brief Self- Control Scale (BSCS) in motorcyclists. Int J Psychiatry Clin Pract. 2020;24(2):176-182. doi: 10.1080/13651501.2019.1711423. PMID: 31913764.
  34. Ghahremanloo M, Kiani Q, Yousefi-Afrashteh M. Relationship between Self-Control and Forgiveness with Duration of Marriage in Couples. International Journal of Behavioral Sciences. 2022; 16(3): 177-182. doi: 10.30491/ ijbs.2022.346485.1813.
  35. Sherer M, Maddux JE, Mercandante B, Prentice- Dunn S, Jacobs B, Rogers RW. The self-efficacy scale: Construction and validation. Journal of Psychology reports. 1982; 51(2):663-71. doi: 10.2466/pr0.1982.51.2.663.
  36. Farnia V, Asadi R, Abdoli N. Psychometric properties of the Persian version of General Self- Efficacy Scale (GSES) among substance abusers the year 2019–2020 in Kermanshah city. Clinical Epidemiology and Global Health. 2020; 8 (3): 949- 953. doi: 10.1016/j.cegh.2020.03.002.
  37. Kelly JF, Hoeppner BB, Urbanoski KA, Slaymaker V. Predicting relapse among young adults: psychometric validation of the advanced warning of relapse (AWARE) scale. Addict Behav. 2011; 36(10):987-93. doi: 10.1016/j.addbeh.2011.05.013. PMCID: PMC3135308.
  38. Taherifard M, Basharpoor S, Hajloo N, Narimani M. The Role of Withdrawal Self-efficacy, Craving and Attention Bias in Predicting of Relapse in Individuals with Methamphetamine Abuse. Journal of Police Medicine.2021; 10 (4): 273-280.
  39. Miller WR, Rose GS. Toward a theory of motivational interviewing. Am Psychol. 2009; 64(6):527-37. doi: 10.1037/a0016830. PMCID: PMC2759607.
  40. Tran TPT, Park J, Park E, Shin SH, Paek YJ, Kim YH, et al. Effect of Additional Motivational Interviewing on Smoking Abstinence for 1-Year among Korean Adolescents: Results from A Comparative Retrospective Study in Quitline. Int J Environ Res Public Health. 2020; 17(21):8025. doi: 10.3390/ijerph17218025. PMCID: PMCID: PMC7662252.
  41. Walpole B, Dettmer E, Morrongiello B, McCrindle B, Hamilton J. Motivational interviewing as an intervention to increase adolescent self-efficacy and promote weight loss: methodology and design. BMC Public Health. 2011;11:459. doi: 10.1186/1471-2458-11-459. PMCID: PMC3144459.
  42. Kumar S, Srivastava M, Srivastava M, Yadav JS, Prakash S. Effect of Motivational Enhancement Therapy (MET) on the self efficacy of Individuals of Alcohol dependence. J Family Med Prim Care. 2021;10(1):367-372. doi: 10.4103/jfmpc. jfmpc_1578_20. Epub 2021 Jan 30. PMCID: PMC8132760.
  43. Dehghani FS, Ghasemi H, Safari S, Ebrahimi AA, Etemadi O. The Effectiveness of Group Motivational Interviewing Sessions on Enhancing of Addicted Women’s Self-Esteem and Self- Efficacy. Etiadpajohi. 2013; 7 (26):145-158. (In Persian)
  44. Locatelli G, Zeffiro V, Occhino G, Rebora P, Caggianelli G, Ausili D, et al. Effectiveness of Motivational Interviewing on contribution to self-care, self-efficacy, and preparedness in caregivers of patients with heart failure: a secondary outcome analysis of the MOTIVATE-HF randomized controlled trial. Eur J Cardiovasc Nurs. 2022;21(8):801-811. doi: 10.1093/eurjcn/zvac013. PMID: 35290454.
  45. Elwyn G, Dehlendorf C, Epstein RM, Marrin K, White J, Frosch DL. Shared decision making and motivational interviewing: achieving patient-centered care across the spectrum of health care problems. Ann Fam Med. 2014; 12(3):270-5. doi: 10.1370/afm.1615. PMCID: PMC4018376.
  46. Kang K, Kim S. The Efficacy of Motivational Interviewing with Cognitive Behavioral Treatment on Behavior Changes in Heavy Drinkers. Sustainability. 2021; 13(3):1338. doi:10.3390/ su13031338.
  47. Maredpour A, Najafy M, Amiri F. The effectiveness of mindfulness-based relapse prevention on the prevention of relapse, craving and self-control in opiate-dependent individuals. Etiadpajohi. 2015; 8 (32):87-104. (In Persian).
  48. Schaub MP, Castro RP, Wenger A, Baumgartner C, Stark L, Ebert DD, et al. Web-based self-help with and without chat counseling to reduce cocaine use in cocaine misusers: Results of a three-arm randomized controlled trial. Internet Interv. 2019; 17:100251. doi: 10.1016/j.invent.2019.100251. PMCID: PMC6536739.
  49. Song T, Qian S, Yu P. Mobile Health Interventions for Self-Control of Unhealthy Alcohol Use: Systematic Review. JMIR Mhealth Uhealth. 2019; 7(1):e10899. doi: 10.2196/10899. PMCID: PMC6371076.
  50. Stautz K, Zupan Z, Field M, Marteau TM. Does self-control modify the impact of interventions to change alcohol, tobacco, and food consumption? A systematic review. Health Psychol Rev. 2018; 12(2):157-178. doi: 10.1080/17437199.2017.1421477. PMID: 29291664.
  51. Heidari A, Mohamadi R, Bahmani M. The Effect of Motivational Interviewing on Reducing Craving and Relapse in Substance Abusers under Methadone Treatment. Etiadpajohi.2017; 11 (43): 89-104. (In Persian)
  52. Asif M, Khoso AB, Husain MA. Culturally adapted motivational interviewing with cognitive behavior therapy and mindfulness-based relapse prevention for substance use disorder in Pakistan (CAMAIB): protocol for a feasibility factorial randomized controlled trial. Pilot and feasibility studies. 2023; 9(1): 67.
  53. Shekarchi R, Akbari M, Ahmadian H, Yarahmadi Y. The Effectiveness of Self-Control Training Program on Reducing Addiction Readiness in Students. JPEN.2021; 8 (2):71-80.
  54. Carter T, Heaton K, Merlo LJ, Roche BT, Puga F. Relapse Prevention and Prediction Strategies in Substance Use Disorder: A Scoping Review. J Addict Nurs. 2023; 34(2):146-157. doi: 10.1097/ JAN.0000000000000527. PMID: 37276204.
  55. Kelly TM, Daley DC. Integrated treatment of substance use and psychiatric disorders. Soc Work Public Health. 2013; 28(3-4):388-406. doi: 10.1080/19371918.2013.774673. PMCID: PMC3753025.